Mannkind (MNKD) Common Equity (2010 - 2026)

Mannkind's (MNKD) quarterly Common Equity came in at -$59.2 million in Q1 2026, down 0.98% year-on-year from -$59.8 million in Q1 2025, and down 16.02% on a QoQ basis from -$51.0 million in Q4 2025.

Mannkind (MNKD) Common Equity (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Common Equity data on file, last reported at -$59.2 million in Q1 2026.

  • On a quarterly basis, Common Equity fell 0.98% year-over-year to -$59.2 million in Q1 2026; TTM through Mar 2026 was -$59.2 million, a 0.98% decrease from a year earlier, with the FY2025 full-year figure at -$51.0 million, up 35.26% from the prior year.
  • Common Equity for Q1 2026 stood at -$59.2 million, down from -$51.0 million in the prior quarter.
  • Over the last five years, Common Equity for MNKD reached as high as -$44.6 million in Q3 2025 and fell as low as -$260.5 million in Q2 2023.
  • Historically, Common Equity has averaged -$176.1 million across 5 years, with a median of -$230.0 million in 2024.
  • Across the five-year window, Common Equity tumbled 34.6% in 2022 and soared 78.78% in 2025, its largest moves.
  • Year by year, Common Equity stood at -$250.5 million in 2022, then climbed by 1.74% to -$246.2 million in 2023, then soared by 67.98% to -$78.8 million in 2024, then surged by 35.26% to -$51.0 million in 2025, then retreated by 16.02% to -$59.2 million in 2026.
  • Per Business Quant data, the three most recent Common Equity figures were -$59.2 million in Q1 2026, -$51.0 million in Q4 2025, and -$44.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn -59.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -59.20 Mn
Dec 31, 2025 -51.02 Mn
Sep 30, 2025 -44.55 Mn
Jun 30, 2025 -55.04 Mn
Mar 31, 2025 -58.62 Mn
Dec 31, 2024 -78.82 Mn
Sep 30, 2024 -209.93 Mn
Jun 30, 2024 -225.78 Mn
Mar 31, 2024 -229.97 Mn
Dec 31, 2023 -246.17 Mn
Sep 30, 2023 -251.78 Mn
Jun 30, 2023 -260.49 Mn
Mar 31, 2023 -255.40 Mn
Dec 31, 2022 -250.54 Mn
Sep 30, 2022 -237.68 Mn
Jun 30, 2022 -247.06 Mn
Mar 31, 2022 -232.06 Mn
Dec 31, 2021 -209.35 Mn
Sep 30, 2021 -184.69 Mn
Jun 30, 2021 -183.55 Mn